Skip to main content

MoneyWorks4Me

Granules India informs about press release

03 Jul 2020 Evaluate

Granules India has informed that the Company enclosed the press release given by Granules Pharmaceuticals, Inc., a wholly owned subsidiary of the Company titled: ‘Granules Pharmaceuticals, Inc. issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..